Please provide your email address to receive an email when new articles are posted on . An MRI-derived, noninvasive tissue biomarker improved autoimmune hepatitis management by distinguishing patients ...

Autoimmune hepatitis responds well to long-term immunosuppression with low-dose glucocorticoids with added azathioprine or mycophenolate in approximately 80 to 90% of treated children. In children ...

The treatment of autoimmune hepatitis is evolving as the pathogenic pathways that underlie the disease are defined, new immunosuppressive agents are tested, and site-specific molecular interventions ...

Please provide your email address to receive an email when new articles are posted on . Aggressive steroid regimens – with doses as high as 60 mg per day – have become the “new mantra” for treating ...